Articles · Mental Health

Depression in Perimenopause: Symptoms, Risk, and Treatment

How hormone swings can affect mood, what the pattern can look like, and why treatment still matters.

7 min read · Published May 30, 2026 · Updated September 29, 2026

Sourced from peer-reviewed research and clinical guidelines, cited at the end of this article. How we write about your body.

Depression in Perimenopause: Symptoms, Risk, and Treatment

Depression in perimenopause is not just a reaction to a hard stretch of midlife. It has a distinct biological basis, a specific pattern in the population, and treatment implications that differ from depression at other times of life. These differences affect whether you get the right treatment.

How Common, and When It Peaks

The Study of Women’s Health Across the Nation (SWAN), which followed more than 3,300 women aged 42 to 52 over thirteen years, found the odds of depressive symptoms rose 1.5 to 2 fold during perimenopause compared with premenopause.[1] The risk peaks in late perimenopause (the one to three years just before the final period) when estrogen is falling most erratically.[1]

A meta-analysis of studies in Chinese perimenopausal women found a depression rate of about 26%, with mild severity most common.[2] Other research has consistently found that women with no prior history of depression face a clearly higher risk during the transition than at any other point in adult life.[3]

This is not only a worsening of existing depression, though that happens too. It is new depression appearing in women who have been mentally well for decades.

What It Looks Like

Perimenopausal depression does not always look like classic low mood with low energy and tearfulness. Research describes it as having anxious and anhedonic features: a flattening of pleasure and reward rather than deep sadness, often with anxiety, irritability, and brain fog.[4]

Women often describe it as losing their usual sense of themselves. Things that used to bring satisfaction, such as work, relationships, and hobbies, feel flat. Combined with poor sleep and fog, it can be mistaken for burnout, life dissatisfaction, or a thyroid problem.

Timing is also informative. Perimenopausal depression tends to worsen in the premenstrual phase of now-irregular cycles, tracking hormone swings rather than a steady low mood all month. That pattern points to a hormonal driver rather than a purely psychological one.

The Biological Mechanism

Estrogen affects the GABA system (which dampens anxiety), serotonin production and receptor binding, and the HPA stress response. When estrogen swings unpredictably, all three become less stable.

A specific demonstration comes from a 2015 randomised trial by Schmidt and colleagues in JAMA Psychiatry.[5] Women with a history of perimenopausal depression were given steady estradiol levels, then had estradiol withdrawn under controlled conditions. Most developed significant depressive symptoms in response to the withdrawal. Women without that history did not. This showed that sensitivity to estrogen swings, rather than low estrogen itself, is the driver in perimenopausal depression.

Treatment: Why the Context Changes the Approach

For postmenopausal depression with no hormonal symptoms alongside, standard antidepressants are appropriate and effective. Perimenopausal depression is a different situation.

The evidence supports estradiol as an effective antidepressant during the transition. A randomised trial using transdermal estradiol (0.1 mg/day) in perimenopausal women with depression found a remission rate of 68% in the estradiol group versus 20% in the placebo group at twelve weeks.[6] The effect appears specific to the transition window: the same research group found estradiol does not work as an antidepressant in women well into the postmenopausal years.[7]

This time-specificity is often missed. The window in which HRT addresses mood at the hormonal level matches the window when hormone swings are the active driver. Once the transition is complete and a new balance is set, the mood benefits of HRT are different in character.

Antidepressants remain appropriate options. SNRIs such as venlafaxine and desvenlafaxine also reduce hot flashes, which makes them useful when both mood and hot flashes are significant. For women who cannot or would rather not use HRT, SSRIs and SNRIs are evidence-based treatments for perimenopausal depression.

The choice between HRT and antidepressants is not all-or-nothing. Many women benefit from both: addressing the hormonal basis with estradiol while also using a low-dose antidepressant. The decision should be made with a clinician who understands the specific context of perimenopausal mood, rather than treating it as identical to a first depressive episode in a 30-year-old.

Who Is at Higher Risk

Several things raise the risk of depression during the transition:

A history of PMS or PMDD. Women who were sensitive to premenstrual hormone shifts are more likely to develop perimenopausal depression. The same sensitivity mechanism is at work, now driven by the larger, less predictable swings of perimenopause rather than the monthly cycle.[3]

A prior depressive episode. Perimenopausal depression can be a first episode, but a prior history substantially raises the risk of recurrence during the transition.

Significant hot flashes. Hot flashes and night sweats break sleep, and sleep loss is both a result and a driver of depression. Low mood worsens hot flashes; hot flashes worsen sleep and mood.

Stressful circumstances. The perimenopausal years often coincide with caregiving demands, relationship changes, and career pressure. These add to the biological vulnerability.

What to Raise With Your Clinician

If you suspect perimenopausal depression rather than, or alongside, situational low mood, it helps to share:

This context helps tell hormonally driven perimenopausal depression apart from a primary depressive disorder, and informs whether estradiol, antidepressants, or a combination is the best starting point.

Frequently Asked Questions

Can menopause itself cause depression?

Once you’re past the transition and into a stable low-estrogen state, the same estradiol treatment that works so well for perimenopausal depression stops working as reliably as an antidepressant.[7] That’s evidence the hormone swings of perimenopause, not menopause’s steady low estrogen itself, are the real driver of new depression during this life stage. A depressive episode that starts after menopause is still worth treating seriously, but it tends to respond more like depression at any other point in life than like the hormonally distinct pattern described above.


References

[1] Bromberger, J. T., Kravitz, H. M., Chang, Y. F., et al. (2011). Major depression during and after the menopausal transition: Study of Women’s Health Across the Nation (SWAN). Psychological Medicine, 41(9), 1879-1888. Cited in: PMC analysis of SWAN depression data. https://pmc.ncbi.nlm.nih.gov/articles/PMC12237151/

[2] Liu, Q., et al. (2023). Risk factors for perimenopausal depression in Chinese women: a meta-analysis. Frontiers in Psychiatry. https://pmc.ncbi.nlm.nih.gov/articles/PMC10598844/

[3] Freeman, E. W., Sammel, M. D., Lin, H., Nelson, D. B. (2006). Associations of hormones and menopausal status with depressed mood in women with no history of depression. Archives of General Psychiatry, 63(4), 375-382. Cited in review: https://pmc.ncbi.nlm.nih.gov/articles/PMC11279181/

[4] Maki, P. M., Kornstein, S. G., Joffe, H., et al. (2019). Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations. Menopause, 26(2), 181-194. Cited in: Menopause and Mental Health. https://pmc.ncbi.nlm.nih.gov/articles/PMC12237151/

[5] Schmidt, P. J., Ben Dor, R., Martinez, P. E., et al. (2015). Effects of estradiol withdrawal on mood in women with past perimenopausal depression: a randomized clinical trial. JAMA Psychiatry, 72(7), 714-726. https://pubmed.ncbi.nlm.nih.gov/26018333/

[6] Soares, C. N., Almeida, O. P., Joffe, H., Cohen, L. S. (2001). Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Archives of General Psychiatry, 58(6), 529-534. Cited in: https://pmc.ncbi.nlm.nih.gov/articles/PMC6309886/

[7] Estradiol in perimenopausal depression: so much promise and so few answers. (2019). Current Psychiatry Reports. https://pmc.ncbi.nlm.nih.gov/articles/PMC6309886/

[8] Joffe, H., Groninger, H., Soares, C. N., Nonacs, R., Cohen, L. S. (2001). An open trial of mirtazapine in menopausal women with depression unresponsive to estrogen replacement therapy. Journal of Women’s Health and Gender-Based Medicine, 10(10), 999-1004. Cited in SSNRIs for co-occurring VMS: https://pmc.ncbi.nlm.nih.gov/articles/PMC12237151/

Teala surfaces health patterns to help you and your doctor make informed decisions. It does not diagnose conditions or replace medical advice. Always consult a qualified healthcare professional about your symptoms and treatment.